VATOR SWISS NORDIC BIO 2022 – The Leading Annual European Healthcare Investor Summit in Zürich.
Vator Securities and Business Sweden & partners have the pleasure to invite you to the annual European healthcare investor conference VATOR SWISS NORDIC BIO, connecting fast growing Nordic publicly listed healthcare companies, the most exciting start-ups, and the European investor community.
In 2022 the conference will return to Zürich Switzerland and take place on March 23rd 2022. Back physical, the conference will be exclusively limited to about 200 participants.
This year’s conference, 2021, was an astounding success with 300 participants from 21 countries, 700 one-on-one investor meetings, and Mikael Dolsten CSO at Pfizer Inc. as keynote speaker. The event was highly appreciated as an attractive way to connect leading healthcare investors with exciting and successful companies.
Vator Swiss Nordic Bio gives exposure to Europe’s leading specialist and generalist investors and fast-growing Nordic healthcare companies including one-on-one meetings.